XPO1

There are 11 papers on XPO1 in aging research: 1 observational study in people, 4 in animals, 5 in cells, 1 review.

Gene

11 papers study it4 findings

HGNCNCBI GeneTaxon

1 new paper in 30 daysSee all 11 papers on XPO1

At a glance

The findings reach people, from one lab or study. 3 independent labs in 2 countries; 4 trials, 1 with no results posted.

“We found that some CH genotypes including JAK2, RUNX1, and XPO1 variants were associated with high hematologic malignancy risk.”
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerBlood advances2023doi:10.1182/bloodadvances.2023011262

None of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 3 independent labs in 2 countries
  • 4 trials, 1 with no results posted
  • Funders: CONACYT and others
  • 1 of 4 findings with company ties
  • 4 of 4 trials sponsored by developers of drugs aimed at it
  • Humans1
  • Animals3
  • Model organisms1
  • Cells5

Effects

2

Nuclear TFEB levels

downin mice1

1 study
  1. XPO1 decreases nuclear TFEB levels in mice (physiological aging).

    “which resulted in a decrease of nuclear TFEB and STAT3”

    Animalsphysiological aginghippocampus and cortex

    Enhanced Activity of Exportin-1/CRM1 in Neurons Contributes to Autophagy Dysfunction and Senescent Features in Old Mouse Brain

    Oxidative medicine and cellular longevity

More on Nuclear TFEB levels

HGPS cellular phenotype

upin human cells1

1 study
  1. XPO1 increases HGPS cellular phenotype in human cells (exogenous overexpression in normal fibroblasts).

    “Exogenous overexpression of CRM1 on the other hand recapitulates the HGPS cellular phenotype in normal fibroblasts.”

    Cellsexogenous overexpression in normal fibroblastsfibroblasts

    Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity

    Aging cell

Upstream

1

Donor age

upin human cells1

1 study
  1. donor age increases XPO1 in human cells (fibroblasts from healthy donors).

    “CRM1 levels/activity increases with age in fibroblasts from healthy donors”

    Cellsfibroblasts from healthy donorsfibroblasts

    Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity

    Aging cell

Associations

1

Hematologic malignancy

upin humans1

1 study
  1. XPO1 is linked with a higher risk of hematologic malignancy in humans (clonal hematopoiesis genotype in patients with nonhematologic cancer).

    “We found that some CH genotypes including JAK2, RUNX1, and XPO1 variants were associated with high hematologic malignancy risk.”

    Humansclonal hematopoiesis genotype in patients with nonhematologic cancern = 42,714

    High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer

    Blood advances

More on Hematologic malignancy

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 12 papers in 12 months

See all 11 papers on XPO1